Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy

Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy - a Randomized Control Trial.

Status

UNKNOWN

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03382743

Enrollment

200

Registered

2017-12-26

Start date

2017-12-20

Completion date

2018-03-31

Last updated

2018-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Uterus

Keywords

office hysteroscopy, Lidocaine spray

Brief summary

lidocaine spray is used endocervical before office hysteroscopy to reduce the pain

Detailed description

5 sprays of Lidocaine is applied 3 minutes before office hysteroscopy

Interventions

DRUGEndocervical Lidocaine spray

5 sprays of endocervical Lidocaine spray (10%) is used 3 minutes before office hysteroscopy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Subject)

Intervention model description

Randomized controlled trial

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 45 Years

Healthy volunteers

Inclusion criteria

Patients indicated for diagnostic hysteroscopy for infertility or AUB. Postmenstrual between days 7 and 11 of the cycle ( except in irregular bleeding)

Exclusion criteria

Contraindication to office hysteroscopy Neurological disorders affecting the evaluation of pain. Previous cervical surgery.

Design outcomes

Primary

Measure	Time frame	Description
Pain sensation	The VAS will be applied immediately after the procedure ended	The level of pelvic pain will be rated according to a 10-point visual analogue scale (VAS)
Procedure time	immediately after the process	from introduction of the office hysteroscopy through the external cervical os and the visualization of the uterine cavity

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026